The increased cancer mortality of diabetes type 2 patients is most likely an evidence of the tight connection between tumor development and energy metabolism. A major focus of todayâ€™s research is still the identification of key proteins of both diseases and the development of corresponding inhibitors. In this study we combined the two-stage BALB/c-3T3 cell transformation assay (BALB-CTA) with the IR/IGF-1R inhibitor OSI-906 (linsitinib) and analyzed alterations in protein activity and energy parameters in non-transformed as well as transformed cells. OSI-906 successfully inhibited the phosphorylation of IR/IGF-1R and decreased cell growth in non-transformed cells. In the BALB-CTA, a permanent treatment with OSI-906 reduced cellular transformation dose-dependently, whereas a temporary treatment gave evidence for a preventive effect in the promotion phase. Furthermore, even though several key proteins were affected, it was possible to show that the phosphorylation of GSK3, Erk 1/2 and the S6 protein are not crucial for the cell foci reducing effect of OSI-906. Taken together, the BALB-CTA confirmed results of OSI-906 from animal studies and enhanced the knowledge of its mode of action. Therefore, the BALB-CTA offers the opportunity to analyze alterations in the transformation process more precisely and will be helpful to identify effective cancer treatments.
cell                0.9999999958532726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_(biology)        

phosphorylation               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phosphorylation       

cells                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_(biology)        

protein                       0.8032935285538256^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

IGF-1R                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Insulin-like_growth_factor_1_receptor

assay                         0.9999999999635065^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Assay                 

energy                        0.9999999704546103^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

foci                          0.9944199203310375^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Focus_(optics)        

inhibitor                     0.9999999999490683^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

phosphorylation               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phosphorylation       

cancer                        0.7201675979071629^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Carcinogenesis        

OSI                           0.9982712955847286^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/OSI_model             

tumor                         0.9989593877625123^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tumor                 

3T3                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/3T3_cells             

OSI                           0.9982712955847286^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/OSI_model             

OSI                           0.9982712955847286^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/OSI_model             

mortality                     0.9995727823226055^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mortality_rate        

energy metabolism             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bioenergetics         

Erk 1/2                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Extracellular_signal-regulated_kinases

cells                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_(biology)        

cancer                        0.7201675979071629^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Carcinogenesis        

proteins                      0.9999999014030485^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

OSI                           0.9982712955847286^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/OSI_model             

cellular transformation       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Transformation_(genetics)

S6                            0.9999963745453678^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ribosomal_protein_s6  

cell growth                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_growth           

IR                            0.9925298359643074^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Infrared_spectroscopy 

proteins                      0.9999999014030485^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

IGF-1R                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Insulin-like_growth_factor_1_receptor

IR                            0.9925298359643074^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Infrared_spectroscopy 

inhibitors                    0.9999999998922249^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

cell transformation           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Malignant_transformation

OSI                           0.9982712955847286^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/OSI_model             

GSK3                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/GSK-3                 

protein                       0.8032935285538256^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

diabetes type 2               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetes_mellitus_type_2

